Influence of Mild Therapeutic Hypothermia on Leukocyte Count

This study is not yet open for participant recruitment.

Verified by Charite University, Berlin, Germany, August 2007

Sponsored by:	Charite University, Berlin, Germany
Information provided by:	Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:	NCT00520520

Purpose

Mild therapeutic hypothermia is indicated in patients surviving out-of-hospital cardiac arrest due to ventricular fibrillation. Potential immunologic responses are unknown.

Condition
Ventricular Fibrillation

Genetics Home Reference related topics: Brugada syndrome short QT syndrome

MedlinePlus related topics: Hypothermia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Longitudinal, Defined Population, Prospective Study

Eligibility

Ages Eligible for Study:	18 Years to 90 Years
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Survivors of cardiac arrest due to VF
Age 18-90

Exclusion Criteria:

Suspected / proven pregancy
Immunodeficiency

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00520520

Contacts

Contact: Joerg C Schefold, MD

0049-450-665537

schefold@charite.de

Locations

Germany
Charite University Hospital
Berlin, Germany, 13353

Sponsors and Collaborators

Charite University, Berlin, Germany

Investigators

Principal Investigator:	Joerg C Schefold, MD	Charite University Medicine Berlin
Principal Investigator:	Christian Storm, MD	Charite University Medicine Berlin

More Information

Study ID Numbers:	I-STU-26
Study First Received:	August 22, 2007
Last Updated:	August 23, 2007
ClinicalTrials.gov Identifier:	NCT00520520
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Charite University, Berlin, Germany:

post resuscitation
post ventricular fibrillation
patients receiving mild therapeutic hypothermia

Study placed in the following topic categories:

Hypothermia
Heart Diseases
Paroxysmal ventricular fibrillation
Ventricular Fibrillation
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009